Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study.
Maiorano BA, Catalano M, Mercinelli C, Roviello G, Maruzzo M, De Giorgi U, Chiellino S, Sbrana A, Galli L, Zucali PA, Masini C, Naglieri E, Procopio G, Merler S, Fratino L, Baldessari C, Ricotta R, Mollica V, Sorarù M, Tudini M, Prati V, Malgeri A, Atzori F, Napoli MD, Caffo O, Spada M, Morelli F, Prati G, Nolè F, Vignani F, Cavo A, Lipari H, Puglisi S, Signori A, Necchi A, Banna GL, Fornarini G, Buti S, Rebuzzi SE.
Maiorano BA, et al. Among authors: morelli f.
Clin Genitourin Cancer. 2024 Nov 10;23(1):102267. doi: 10.1016/j.clgc.2024.102267. Online ahead of print.
Clin Genitourin Cancer. 2024.
PMID: 39603144